| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |